IP Library Granted Patent US 7,018,599
Granted Patent B2
US 7,018,599 · App. 10/846,646 · Granted Mar 28, 2006

Fullerene derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,018,599
App. No.
10/846,646
Granted
Mar 28, 2006
Kind
B2
Abstract

A novel means for DNA compaction is provided. The object is accomplished by providing a fullerene derivative having 1 to 4 nitrogen-containing hydrophilic side chain(s) or its salt for DNA compaction. DNA compaction can be achieved effectively, and application to gene therapy is also expected.

Claims (12)

1. A fullerene derivative of the following general formula or a salt thereof:

wherein the two Rs may be the same or different and each represents a straight-chain or branched-chain acyl group comprising 1 to 10 nitrogen atoms and 2 to 30 carbon atoms or hydrogen,

with the provisos that:

(1) the two Rs are not both hydrogen;

(2) said fullerene derivative does not have the following formula:

2. The fullerene derivative or salt thereof of claim 1 , wherein the two Rs are the same or different and each represents a straight-chain or branched-chain acyl group comprising 2 to 8 nitrogen atoms and 2 to 20 carbon atoms.

3. The fullerene derivative or salt thereof of claim 1 , wherein the two Rs are the same or different and each represents a [N-(N,N-di(lower)alkylamino)(lower)alkyl-N-(lower)alkyl]amino(lower)alkanoyl group.

4. A fullerene derivative of the following general formula or a salt thereof:

wherein R represents a straight-chain or branched-chain acyl group comprising 1 to 10 nitrogen atoms and 2 to 30 carbon atoms and R′ represents hydrogen or a lower alkyl group,

with the proviso that said fullerene derivative does not have the following formula:

5. The fullerene derivative or salt thereof of claim 4 , wherein R represents a straight-chain or branched-chain acyl group comprising 2 to 8 nitrogen atoms and 2 to 20 carbon atoms.

6. The fullerene derivative or salt thereof of claim 4 , wherein R is an [N-(N,N-di(lower)alkylamino)(lower)alkyl-N-(lower)alkyl]amino(lower)alkanoyl group.

Assignments (1)
MERGER Recorded Dec 12, 2005
From: FUJISAWA PHARMACEUTICAL CO., LTD.
To: ASTELLAS PHARMA INC.
Reel/Frame 017073/0257 →